Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cronos Australia Ltd. ( (AU:VIT) ) has provided an update.
Vitura Health Limited has notified the market that a tranche of 2,216,676 options, exercisable at $0.2415 and due to expire on August 31, 2031, has lapsed unexercised as of March 12, 2026. The cessation of these options trims the pool of potential future equity dilution for existing shareholders and slightly simplifies the company’s capital structure, though it does not immediately alter issued share capital.
The announcement is a routine Appendix 3H filing to the ASX, formally recording the expiry of these convertible securities without conversion. While operational implications are minimal, the move clarifies Vitura Health’s outstanding securities profile and may be of interest to investors tracking option overhang and potential future capital raising avenues.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited, listed on the ASX under the code VIT, operates in the healthcare sector, though this filing provides only capital markets information rather than details of its specific products, services, or market focus. The company is identified by its Australian Company Number 629071594 and is subject to ASX listing and reporting requirements.
Average Trading Volume: 305,700
Technical Sentiment Signal: Sell
Current Market Cap: A$27.17M
See more data about VIT stock on TipRanks’ Stock Analysis page.